{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T19:45:20Z","timestamp":1775677520281,"version":"3.50.1"},"reference-count":23,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2012,8,9]],"date-time":"2012-08-09T00:00:00Z","timestamp":1344470400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl J Gynecology &amp; Obste"],"published-print":{"date-parts":[[2012,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:label\/><jats:p>Misoprostol is an effective and safe uterotonic for the prevention and treatment of postpartum hemorrhage (PPH). A 600\u2010\u03bcg oral dose of misoprostol has been shown to prevent PPH in community\u2010based randomized controlled trials. An 800\u2010\u03bcg sublingual dose of misoprostol appears to be a good first\u2010line treatment for controlling PPH. Adverse effects after use of misoprostol for PPH prevention or treatment may include shivering and fever. These effects are transient, resolve on their own, and are not life threatening. Misoprostol can play an important role in settings with limited access to oxytocin, and where there is no other option for PPH care.<\/jats:p><\/jats:sec>","DOI":"10.1016\/j.ijgo.2012.03.013","type":"journal-article","created":{"date-parts":[[2012,8,9]],"date-time":"2012-08-09T05:03:06Z","timestamp":1344488586000},"source":"Crossref","is-referenced-by-count":16,"title":["Misoprostol for prevention and treatment of postpartum hemorrhage: What do we know? What is next?"],"prefix":"10.1002","volume":"119","author":[{"given":"Sheila","family":"Raghavan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverly","family":"Winikoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,8,9]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2007.09.012"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2007.09.013"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69522-6"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2010.02807.x"},{"key":"e_1_2_7_6_2","unstructured":"World Health Organization.WHO Model Lists of Essential Medicines.17th edition. March2011 Available at:http:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/en\/"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61924-3"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61923-1"},{"issue":"3","key":"e_1_2_7_9_2","first-page":"CD000494","article-title":"Prostaglandins for preventing postpartum haemorrhage","author":"G\u00fclmezoglu A.M.","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2005.00711.x"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.331.7519.723"},{"key":"e_1_2_7_12_2","volume-title":"WHO Statement regarding the use of misoprostol for postpartum haemorrhage prevention and treatment","author":"World Health Organization","year":"2009"},{"key":"e_1_2_7_13_2","volume-title":"WHO guidelines for the management of postpartum haemorrhage and retained placenta","author":"World Health Organization","year":"2009"},{"issue":"2","key":"e_1_2_7_14_2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijgo.2007.02.012","article-title":"Prevention and treatment of post\u2010partum haemorrhage: New advances for low\u2010resource settings. Joint statement","volume":"97","author":"International Confederation of Midwives","year":"2007","journal-title":"Int J Gynecol Obstet"},{"key":"e_1_2_7_15_2","volume-title":"Prevention and management of postpartum haemorrhage. Green\u2010top guideline No. 52","author":"Royal College of Obstetricians and Gynaecologists","year":"2009"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.08.055715"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1999.tb08266.x"},{"issue":"5","key":"e_1_2_7_18_2","first-page":"432","article-title":"Side\u2010effects of oral misoprostol in the third stage of labour \u2013 a randomised placebo\u2010controlled trial","volume":"91","author":"Hofmeyr G.J.","year":"2001","journal-title":"S Afr Med J"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2010.02564.x"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2004.00512.x"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/17.2.332"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60348-0"},{"issue":"4","key":"e_1_2_7_23_2","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/00006250-200610000-00046","article-title":"ACOG Practice Bulletin No. 76: Postpartum hemorrhage","volume":"108","author":"American College of Obstetricians and Gynecologists","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"2","key":"e_1_2_7_24_2","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ijgo.2012.03.001","article-title":"Prevention and treatment of postpartum hemorrhage in low\u2010resource settings","volume":"117","author":"FIGO Safe Motherhood and Newborn Health Committee","year":"2012","journal-title":"Int J Gynecol Obstet"}],"container-title":["International Journal of Gynecology &amp; Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1016%2Fj.ijgo.2012.03.013","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1016%2Fj.ijgo.2012.03.013","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0020729212001543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0020729212001543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1016\/j.ijgo.2012.03.013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T16:44:17Z","timestamp":1695573857000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1016\/j.ijgo.2012.03.013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,9]]},"references-count":23,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["10.1016\/j.ijgo.2012.03.013"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgo.2012.03.013","archive":["Portico"],"relation":{},"ISSN":["0020-7292","1879-3479"],"issn-type":[{"value":"0020-7292","type":"print"},{"value":"1879-3479","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,9]]}}}